年別の研究成果
年別の研究成果
- 19 件
検索結果
-
2022
Three doses of mRNA COVID-19 vaccine protects from SARS-CoV-2 infections in Japan
Hotta, K., Suzuki, E., Ichihara, E. & Kiura, K., 2022, (Accepted/In press) In: Journal of Internal Medicine.研究成果 › 査読
-
2021
Response to letter re: The effects of antibiotics on the efficacy of immune-checkpoint inhibitors in non-small cell lung cancer patients differ according to PD-L1 expression
Ochi, N., Ichihara, E., Takigawa, N., Harada, D., Inoue, K., Shibayama, T., Hosokawa, S., Kishino, D., Harita, S., Oda, N., Hara, N., Hotta, K., Maeda, Y. & Kiura, K., 11月 2021, In: European Journal of Cancer. 157, p. 523-524 2 p.研究成果 › 査読
-
2020
Patients’ preferences and perceptions of lung cancer treatment decision making: results from Okayama lung cancer study group trial 1406
Makimoto, G., Hotta, K., Oze, I., Ninomiya, K., Nakanishi, M., Hara, N., Kano, H., Watanabe, H., Hata, Y., Nishii, K., Nakasuka, T., Itano, J., Ninomiya, T., Kubo, T., Ohashi, K., Ichihara, E., Minami, D., Sato, A., Tabata, M., Maeda, Y., & 1 others, 3月 3 2020, In: Acta Oncologica. 59, 3, p. 324-328 5 p.研究成果 › 査読
1 被引用数 (Scopus) -
2015
Challenges in Bevacizumab and Gefitinib combination therapy for patients with non-small-cell lung cancer
Ichihara, E., Hotta, K. & Kiura, K., 8月 1 2015, In: Journal of Thoracic Oncology. 10, 8, p. e79研究成果 › 査読
-
Reappraisal of short-term low-volume hydration in cisplatin-based chemotherapy; hoping for it as a public domain
Hotta, K., Ninomiya, K., Takigawa, N., Tanimoto, M. & Kiura, K., 6月 1 2015, In: Japanese journal of clinical oncology. 45, 6, p. 603-604 2 p., hyv065.研究成果 › 査読
14 被引用数 (Scopus) -
2014
A Survey of Japanese Thoracic Oncologists' Perception of Diagnostic and Treatment Strategies for EGFR Mutant or EML4-ALK Fusion Non-small Cell Lung Cancer
Hotta, K., Kiura, K., Tabata, M., Takigawa, N., Tanimoto, M. & Ueoka, H., 12月 1 2014, In: Chest. 146, 6, p. e222-e225研究成果 › 査読
4 被引用数 (Scopus) -
2013
Extrapulmonary small cell carcinoma mimicking malignant pleural mesothelioma
Noguchi, K., Fujimoto, N., Asano, M., Fuchimoto, Y., Ono, K., Ozaki, S., Hotta, K., Kato, K., Toda, H., Taguchi, K. & Kishimoto, T., 5月 2013, In: Journal of Clinical Pathology. 66, 5, p. 450-451 2 p.研究成果 › 査読
2 被引用数 (Scopus) -
2011
Cure- Or Care-oriented regimen for stage III non-small-cell lung cancer?
Hotta, K., Takigawa, N., Matsuo, K. & Kiura, K., 4月 10 2011, In: Journal of Clinical Oncology. 29, 11, p. e320研究成果 › 査読
6 被引用数 (Scopus) -
2010
In response
Hotta, K., Takigawa, N. & Kiura, K., 11月 2010, In: Journal of Thoracic Oncology. 5, 11, p. 1878 1 p.研究成果 › 査読
-
2009
A case of advanced non-small-cell lung cancer who responded slowly to gefitinib monotherapy after long-term disease stabilization
Hotta, K., Kiura, K., Shirahige, A., Takata, S., Takigawa, N., Tabata, M., Watanabe, H. & Tanimoto, M., 2009, In: Acta Oncologica. 48, 3, p. 471-473 3 p.研究成果 › 査読
1 被引用数 (Scopus) -
2008
Paradoxical clinical effects of epidermal growth factor receptor-tyrosine kinase inhibitors for acute myelogenous leukemia
Hotta, K., Kiura, K., Takigawa, N., Matsuo, K., Tabata, M., Fujiwara, Y. & Tanimoto, M., 12月 10 2008, In: Journal of Clinical Oncology. 26, 35, p. 5826-5827 2 p.研究成果 › 査読
4 被引用数 (Scopus) -
Re:"KL-6 and poor prognosis in NSCLC patients treated with gefitinib"
Fujiwara, Y., Hotta, K. & Kiura, K., 1月 2008, In: Lung Cancer. 59, 1, 1 p.研究成果 › 査読
-
2007
Long-standing debate on cisplatin- versus carboplatin-based chemotherapy in the treatment of advanced non-small cell lung cancer [1]
Hotta, K. & Matsuo, K., 1月 2007, In: Journal of Thoracic Oncology. 2, 1, p. 96 1 p.研究成果 › 査読
31 被引用数 (Scopus) -
Reply to recent improvement in the survival of patients with advanced nonsmall cell lung cancer enrolled in phase III trials of first-line, systemic chemotherapy [2]
Hotta, K., Fujiwara, Y. & Matsuo, K., 12月 1 2007, In: Cancer. 110, 11, p. 2594 1 p.研究成果 › 査読
2 被引用数 (Scopus) -
2006
Role of platinum-based radio-chemotherapy for locally advanced non-small-cell lung cancer: Possible influence of type of platinum on survival data [6]
Hotta, K. & Kiura, K., 11月 2006, In: Annals of Oncology. 17, 11, p. 1724 1 p.研究成果 › 査読
4 被引用数 (Scopus) -
2005
Gefitinib should be cautiously administered to poor performance status patients with non-small-cell lung cancer: Results from a prospective feasibility study [1]
Hotta, K., Inoue, A., Kiura, K., Ueoka, H., Tanimoto, M. & Nukiwa, T., 12月 1 2005, In: Lung Cancer. 50, 3, p. 413-415 3 p.研究成果 › 査読
9 被引用数 (Scopus) -
In reply [6]
Hotta, K., Matsuo, K. & Ueoka, H., 12月 1 2005, In: Journal of Clinical Oncology. 23, 4, p. 925-926 2 p.研究成果 › 査読
-
They also serve who only stand and wait: Do individual clinical researchers, too? Hoping for individual patient data as public domain [16]
Matsuo, K., Hotta, K. & Ueoka, H., 2月 20 2005, In: Journal of Clinical Oncology. 23, 6, p. 1334-1335 2 p.研究成果 › 査読
3 被引用数 (Scopus) -
Toxicity data in addition to survival data are important in evaluating the applicability of a chemotherapy regimen of advanced non-small-cell lung cancer [2]
Hotta, K., Matsuo, K. & Ueoka, H., 8月 2005, In: Lung Cancer. 49, 2, p. 277 1 p.研究成果 › 査読
1 被引用数 (Scopus)